Abstract
This study aimed to investigate the association between hypertensive disorders of pregnancy (HDP) and subsequent risk of dementia using a systematic review and meta-analysis of cohort studies. We searched PubMed and Scopus for eligible studies that investigated the association between HDP and dementia risk. Using the random-effects model, pooled hazard ratio (HR) and 95% confidence interval (CI) of dementia risk in women with HDP were calculated. We applied the I2 statistic to measure heterogeneity across studies and the test for funnel plot asymmetry to evaluate publication bias. Six cohort studies were eligible: three from the United States, two from Sweden, and one from Denmark. When combined, HDP was associated with the risk of dementia: pooled HR (95% CI) = 1.31 (1.12, 1.53). The heterogeneity across studies was moderate (I2 = 47.3%, p-heterogeneity = 0.091), but no signs of publication bias were detected. The association of HDP with vascular dementia was stronger than that with Alzheimer’s disease: pooled HRs (95% CIs) = 1.66 (1.13, 2.43) and 1.29 (0.97, 1.72), respectively. In conclusion, HDP was associated with a higher risk of dementia and this association was more prominent with vascular dementia.
Similar content being viewed by others
Introduction
Alongside aging societies, especially in Western and East-Asian countries, the prevalence and incidence of dementia have been critically increasing [1]. Dementia is characterized by a wide range of cognitive symptoms affecting patients’ memory, perception, orientation, judgment, intelligence, and attention [2]. It also has profound societal and financial burdens that affect patients and their relatives, making it a challenge to healthcare systems [3, 4]. However, a significant proportion of dementia cases can be prevented by managing medical conditions associated with it [5].
Hypertension is among the most significant risk factors for dementia, and controlling blood pressure was shown to preserve cognitive functions and reduce dementia risk [6]. Hypertensive disorders of pregnancy (HDP) include chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP syndrome, a condition characterized by hemolysis, elevated liver enzymes, and low platelets [7]. In addition to being a common complication during pregnancy [7], HDP may confer an increased risk of cognitive decline [8,9,10]. Vasoactive substances released in HDP may lead to brain edema and consequently white matter lesions [11]. These lesions are associated with cognitive decline and dementia progression [12]. Besides, STOX1, a preeclampsia susceptibility gene, can control a conserved pathway in the placenta and brain upregulated in late-onset Alzheimer’s disease (AD) [13]. Furthermore, transthyretin, a transport protein in the plasma and cerebrospinal fluid that transmits the thyroid hormone and retinol to the liver, is similarly dysregulated in preeclampsia and AD [14].
Nevertheless, the epidemiological evidence regarding the link between HDP and dementia is marked by inconsistency. While certain studies have observed an elevated risk of dementia in women with HDP [15,16,17,18], others have not been able to replicate this finding [19,20,21,22]. Furthermore, past meta-analyses have been constrained by the limited number of studies and cases of both HDP and dementia [23,24,25]. These factors in addition to more recent studies that were not included in previous meta-analyses [17, 18] prompted us to perform an updated meta-analysis to investigate the connection between HDP and the risk of all-cause dementia, vascular dementia, and AD.
Methods
We reported this meta-analysis according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) checklist [26]. However, the meta-analysis was not registered in advance with the International Prospective Register of Systematic Reviews (PROSPERO).
Literature search
AA and MT independently searched PubMed and Scopus databases for potential studies published in English language before the 25th of August 2023 using the following terms: ((Gestational hypertension) OR (Preeclampsia)) AND (Dementia) (Supplementary Table 1). Besides, the reference sections of retrieved studies and relevant review articles were checked for potential studies.
Eligibility criteria
Our eligibility criteria included: 1) the exposure was HDP or any of its subtypes, 2) the outcome was incident dementia or any of its subtypes, and 3) the study had a cohort design. We did not apply limitations regarding the year of publication. No efforts were made to obtain unpublished data or studies published in a language other than English.
Data extraction
The following information was extracted from the included studies: the last name of the first author, publication year, place of study, age of participants, the total number of participants, the number of participants with incident dementia, diagnostic methods of HDP and dementia, and covariates included in the most adjusted regression models.
Risk of bias
AA and MT assessed the risk of bias using the modified Newcastle-Ottawa Quality Assessment Scale in terms of studies’ selection, comparability, and outcome [27], with disagreements solved by discussion.
Statistical analysis
We extracted the hazard ratios (HRs) and their 95% confidence intervals (CIs) of dementia, vascular dementia, and AD in women with HDP history in the most adjusted regression models before calculating the pooled HR (95% CI) using the random-effects model [28]. We also performed the I2 statistic to evaluate heterogeneity across studies [29] and the test for funnel plot asymmetry to assess publication bias [30]. The R-3.2.0 statistical package (Metafor: Meta-Analysis Package for R) was used for analysis [31].
Results
First, we removed duplicates, irrelevant records, review articles, studies with designs other than cohort design, and studies that did not assign dementia as an outcome or HDP as an exposure (Fig. 1). We excluded a cohort study that assigned AD mortality as an outcome [32]. We excluded another cohort study that detected only one case of dementia in the preeclampsia group compared to no cases in the normotensive group [9]. Of note, two studies by Andolf et al. assessed similar populations [19, 21]. While the earlier study investigated all forms of HDP separately and together [19], the later study limited the analysis to preeclampsia in one analysis and gestational hypertension in another [21]. Therefore, we decided to include the earlier study [19] in the main meta-analysis and perform sensitivity analyses using the results of the later study [21].
Eventually, six cohort studies were included [15,16,17,18,19,20]. Of them, three studies were conducted in the United States [16,17,18], two studies in Sweden [19, 20], and one study in Denmark [15]. The definition of HDP varied across studies: Basit et al. [15]: preeclampsia, eclampsia, and the HELLP syndrome; Garovic et al. [16]: chronic hypertension, gestational hypertension, preeclampsia superimposed on chronic hypertension, preeclampsia, and eclampsia; Schliep et al. [17]: preeclampsia and eclampsia; Wang et al. [18]: preeclampsia; Andolf et al. [19]: hypertension with or without proteinuria, preeclampsia, and eclampsia; and Nelander et al. [20]: hypertension during pregnancy with or without proteinuria. Data about HDP were self-reported in two studies [18, 20] and were obtained from medical registries in four studies [15,16,17, 19] (Table 1). No significant risks of bias were detected (Supplementary Table 2).
The weights of the included studies were distributed as follows: Basit et al. [15]: 24.7%; Garovic et al. [16]: 7.4%; Schliep et al. [17]: 36.8%; Wang et al. [18]: 12.7%; Andolf et al. [19]: 6.8%; and Nelander et al. [20]: 11.6%. In the meta-analysis, HDP was positively associated with the risk of dementia: pooled HR (95% CI) = 1.31 (1.12, 1.53). The heterogeneity across studies was moderate (I2 = 47.3% and p-heterogeneity = 0.091) (Fig. 2). No signs of publication bias were identified (Z = −0.583, and p-publication bias = 0.560) (Supplementary Fig. 1).
Compared to the results of the earlier Andolf et al. study [19] that showed an HR (95% CI) of 0.66 (0.38, 1.14), the HRs (95% CIs) of their later study [21] were 0.98 (0.87, 1.10) for preeclampsia and 1.10 (0.93, 1.29) for gestational hypertension. When we applied the results of preeclampsia or gestational hypertension from the later study instead of HDP results from the earlier study, the pooled HRs (95% CIs) of the meta-analyses did not materially change: 1.28 (1.07, 1.53) and 1.30 (1.16, 1.45), respectively.
The association of HDP with vascular dementia: pooled HR (95% CI) = 1.66 (1.13, 2.43) with (I2 = 28.79% and p-heterogeneity = 0.246) (Fig. 3) was stronger than the corresponding association with AD: pooled HR (95% CI) = 1.29 (0.97, 1.72) with (I2 = 68.1% and p-heterogeneity = 0.044) (Fig. 4).
Discussion
This meta-analysis combined results from six cohort studies and indicated a positive association between HDP and dementia risk, and the association was stronger with vascular dementia.
A few meta-analyses investigated the association between HDP and dementia. One meta-analysis pooled the unadjusted relative risks (RR) of HDP in three studies: 1.34 (1.11, 1.62) [15], 2.00 (1.20, 3.34) [16]), and (1.09 (0.76, 1.57) [20], but failed to find a statistically significant association: pooled RR (95% CI) = 1.37 (0.70, 2.71) [23]. However, the unadjusted RRs (95% CIs), as calculated by the authors of the meta-analysis, suggest that the 95% CI of the pooled results should have been much tighter and a statistically significant association between HDP and dementia should have been concluded. Another meta-analysis of two cohort studies [15, 21] showed no association between HDP and dementia risk: HR (95% CI) = 1.08 (0.93, 1.25) [24]. Both meta-analyses were limited by the small number of included studies, making their representativeness questionable. A larger meta-analysis of five cohort studies [9, 15, 20, 21, 32] showed that HDP was significantly associated with the risk of dementia: HR (95% CI) = 1.38 (1.18, 1.61) [25]. However, it included a study assigning AD-attributed mortality as an outcome rather than incident dementia [32] and a study mixing dementia with mild cognitive impairment [9]. Furthermore, more recent studies [16,17,18] were not included. The three recent studies together contributed to 56.9% of our meta-analysis weight.
Importantly, the association between HDP and dementia can vary by dementia subtype. Previous meta-analyses [24, 25], as well as our meta-analysis, showed a stronger association between HDP and vascular dementia than AD. Additionally, the association between HDP and dementia risk could vary by HDP subtype and severity. Andolf et al. [19] showed that hypertension without proteinuria and preeclampsia without severe features were negatively associated with all-cause and vascular dementia, while hypertension with proteinuria, preeclampsia with severe features, and eclampsia were positively associated with all-cause and vascular dementia. Therefore, future studies should consider stratifying their results by dementia subtypes and HDP subtypes and severity.
Of note, it could be speculated that the long-term adverse events associated with HDP, such as chronic hypertension, diabetes mellitus, chronic kidney disease, and stroke [33,34,35], can mediate the association between HDP and dementia. Mid‐life cardiometabolic and mental health factors were shown to explain more than 60% of the association between HDP and subsequent dementia [17].
Strengths and limitations
One of the main strengths of this meta-analysis is the relatively large numbers of HDP and dementia cases. Besides, the population-based design of the included studies suggests their representativeness for the studied populations. Further, the cohort design of the included studies allowed for a long follow-up period between HDP diagnosis and incident dementia. However, several limitations should be addressed as well. First, although our meta-analysis included more studies than the previous ones, the number of included studies is small, and even fewer studies assessed the relationship of HDP with vascular dementia and AD. Therefore, the results, especially those of dementia subtypes, should be interpreted with caution. Second, data about dementia and HDP in most studies were collected using registries that could be prone to selection bias [36]. Third, HDP in two studies was self-reported [18, 20], suggesting recall bias. Fourth, since many studies did not adjust their results for potential confounders and essential mid-life cardiometabolic factors, it is difficult to conclude whether HDP independently elevated the risk of dementia or merely unmasked underlying risk factors for dementia. For example, smoking is associated with both HDP and dementia [37, 38]. Fifth, each study defined HDP differently. This could be partly explained by the variations in HDP definitions across medical societies worldwide [39]. Yet, because of the limited number of studies and the overlap of HDP definitions across them, we could not stratify our meta-analysis by HDP subtypes. Sixth, the investigated women came from Western nations; thus, applying the results to non-Western women should be done cautiously.
Perspective of Asia
HDP is associated with a higher risk of dementia. However, future studies investigating this association among Asian women are needed.
Conclusion
In this meta-analysis, HDP was associated with an elevated risk of dementia, especially vascular dementia. Still, more studies are needed to confirm our findings. Future studies should include women from different ethnicities and consider stratifying results by subtypes of HDP and dementia. Additionally, further studies to explain the potential underlying biological links between HDP and dementia are also needed.
Data availability
All data generated or analyzed during this study were included in this published article.
References
GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105–e25.
Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia: review. JAMA. 2019;322:1589–99.
Seidel D, Thyrian JR. Burden of caring for people with dementia - comparing family caregivers and professional caregivers. A descriptive study. J Multidiscip Health. 2019;12:655–63.
Durgante H, Contreras ML, Backhouse T, Mavrodaris A, Ferreira MG, Paulo DLV, et al. Challenges in dementia care: comparing key issues from Brazil and the United Kingdom. Dement Neuropsychol. 2020;14:216–22.
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413–46.
Sierra C. Hypertension and the risk of dementia. Front Cardiovasc Med. 2020;7:5.
Metoki H, Iwama N, Hamada H, Satoh M, Murakami T, Ishikuro M, et al. Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertens Res. 2022;45:1298–309.
Postma IR, Bouma A, Ankersmit IF, Zeeman GG. Neurocognitive functioning following preeclampsia and eclampsia: a long-term follow-up study. Am J Obstet Gynecol. 2014;211:37.e1–9.
Fields JA, Garovic VD, Mielke MM, Kantarci K, Jayachandran M, White WM, et al. Preeclampsia and cognitive impairment later in life. Am J Obstet Gynecol. 2017;217:74.e1–74.e11.
Miller KB, Miller VM, Barnes JN. Pregnancy history, hypertension, and cognitive impairment in postmenopausal women. Curr Hypertens Rep. 2019;21:93.
Soma-Pillay P, Suleman FE, Makin JD, Pattinson RC. Cerebral white matter lesions after pre-eclampsia. Pregnancy Hypertens. 2017;8:15–20.
Targosz-Gajniak M, Siuda J, Ochudło S, Opala G. Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer’s disease. J Neurol Sci. 2009;283:79–82.
van Dijk M, van Bezu J, Poutsma A, Veerhuis R, Rozemuller AJ, Scheper W, et al. The pre-eclampsia gene STOX1 controls a conserved pathway in placenta and brain upregulated in late-onset Alzheimer’s disease. J Alzheimers Dis. 2010;19:673–9.
Kalkunte SS, Neubeck S, Norris WE, Cheng SB, Kostadinov S, Vu Hoang D, et al. Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model. Am J Pathol. 2013;183:1425–36.
Basit S, Wohlfahrt J, Boyd HA. Pre-eclampsia and risk of dementia later in life: nationwide cohort study. BMJ. 2018;363:k4109.
Garovic VD, White WM, Vaughan L, Saiki M, Parashuram S, Garcia-Valencia O, et al. Incidence and long-term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol. 2020;75:2323–34.
Schliep KC, Shaaban CE, Meeks H, Fraser A, Smith KR, Majersik JJ, et al. Hypertensive disorders of pregnancy and subsequent risk of Alzheimer’s disease and other dementias. Alzheimers Dement. 2023;15:e12443.
Wang K, Guo K, Ji Z, Liu Y, Chen F, Wu S, et al. Association of preeclampsia with incident dementia and Alzheimer’s disease among women in the Framingham Offspring Study. J Prev Alzheimers Dis. 2022;9:725–30.
Andolf EG, Sydsjö GC, Bladh MK, Berg G, Sharma S. Hypertensive disorders in pregnancy and later dementia: a Swedish National Register Study. Acta Obstet Gynecol Scand. 2017;96:464–71.
Nelander M, Cnattingius S, Åkerud H, Wikström J, Pedersen NL, Wikström AK. Pregnancy hypertensive disease and risk of dementia and cardiovascular disease in women aged 65 years or older: a cohort study. BMJ Open. 2016;6:e009880.
Andolf E, Bladh M, Möller L, Sydsjö G. Prior placental bed disorders and later dementia: a retrospective Swedish register-based cohort study. BJOG. 2020;127:1090–9.
Abheiden CN, van Doornik R, Aukes AM, van der Flier WM, Scheltens P, de Groot CJ. Hypertensive disorders of pregnancy appear not to be associated with Alzheimer’s disease later in life. Dement Geriatr Cogn Dis Extra. 2015;5:375–85.
Sukmanee J, Liabsuetrakul T. Risk of future cardiovascular diseases in different years postpartum after hypertensive disorders of pregnancy: a systematic review and meta-analysis. Medicine. 2022;101:e29646.
Samara AA, Liampas I, Dadouli K, Siokas V, Zintzaras E, Stefanidis I, et al. Preeclampsia, gestational hypertension and incident dementia: a systematic review and meta-analysis of published evidence. Pregnancy Hypertens. 2022;30:192–7.
Schliep KC, Mclean H, Yan B, Qeadan F, Theilen LH, de Havenon A, et al. Association between hypertensive disorders of pregnancy and dementia: a systematic review and meta-analysis. Hypertension. 2023;80:257–67.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed on 6 July 2022.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1–48.
Theilen LH, Fraser A, Hollingshaus MS, Schliep KC, Varner MW, Smith KR, et al. All-cause and cause-specific mortality after hypertensive disease of pregnancy. Obstet Gynecol. 2016;128:238–44.
Pankiewicz K, Szczerba E, Maciejewski T, Fijałkowska A. Non-obstetric complications in preeclampsia. Prz Menopauzalny. 2019;18:99–109.
Rayes B, Ardissino M, Slob EAW, Patel KHK, Girling J, Ng FS. Association of hypertensive disorders of pregnancy with future cardiovascular disease. JAMA Netw Open. 2023;6:e230034.
Melchiorre K, Thilaganathan B, Giorgione V, Ridder A, Memmo A, Khalil A. Hypertensive disorders of pregnancy and future cardiovascular health. Front Cardiovasc Med. 2020;7:59.
Strandhagen E, Berg C, Lissner L, Nunez L, Rosengren A, Torén K, et al. Selection bias in a population survey with registry linkage: potential effect on socioeconomic gradient in cardiovascular risk. Eur J Epidemiol. 2010;25:163–72.
Lewandowska M, Więckowska B. The influence of various smoking categories on the risk of gestational hypertension and pre-eclampsia. J Clin Med. 2020;9:1743.
Zhong G, Wang Y, Zhang Y, Guo JJ, Zhao Y. Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS One. 2015;10:e0118333.
Braunthal S, Brateanu A. Hypertension in pregnancy: pathophysiology and treatment. SAGE Open Med. 2019;7:2050312119843700.
Funding
This study was supported by the Intramural Research Fund (20-4-9) for the cardiovascular diseases of the National Cerebral and Cardiovascular Center, the JST Grant Number JPMJPF2018, and the Japan Agency for Medical Research and Development (dk0207025).
Author information
Authors and Affiliations
Contributions
All authors made a substantial contribution to this work. Conceptualization (AA and YK), data collection (AA and MT), analysis and manuscript writing (AA), resources (YK), and revision and editing (AA, RK, MT, YS, SN, KS, HK, QG, CM, and YK).
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Arafa, A., Kashima, R., Shimamoto, K. et al. Hypertensive disorders of pregnancy and the risk of dementia: a systematic review and meta-analysis of cohort studies. Hypertens Res 47, 859–866 (2024). https://doi.org/10.1038/s41440-023-01520-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-023-01520-7
Keywords
This article is cited by
-
Dementia: a looming threat for women with hypertensive disorders of pregnancy?
Hypertension Research (2024)